Using peak amplitude spectral PA measurements in the range of 570 -600 nm, we found it possible to quantify blood oxygenation levels. Visible light illumination minimizes the inversion error of the PA measurements. Owing to high blood absorption in this optical regime, there is also an improved signal-to-noise ratio and less influence from optical scattering. To arrive at correct, and vessel size independent, SO 2 measurements, the central frequency of the ultrasonic transducer must be high enough to satisfy the relation 1 < Λ a µ , that is above 25 MHz for a chosen optical wavelength region, although lower frequency transducers may produce correct results after correction of the optical absorption spectra. However, additional efforts are needed to achieve accurate SO 2 values for in vivo measurements.
INTRODUCTION
The quantification of localized chromophore concentrations in biological tissues from signature optical absorption spectra has a wide range of applications in the biomedical field. Hemoglobin is an important chromophore that exists in two distinct forms, and the concentration ratio of the two forms defines the oxygen carrying capacity of blood. Research has shown that oxygenation level affects the healing of burns 1 and wounds 2 and determines the effectiveness of chemo-and radio-therapy 3 for cancer. Hence, localized noninvasive oxygenation measurements in skin are critical in dermatology, cancer research and plastic surgery. Currently, pulse oximetry, based on near infra-red spectroscopy (NIRS) is widely used in clinical settings although this technique yields single point measurements of arterial blood oxygenation only and, therefore, lacks spatial resolution 4 .
Photoacoustic (PA) imaging is a novel modality that employs laser induced acoustic waves based on the principle of thermal expansion following optical energy absorption by the sample. Since the pressure generated is directly proportional to the local light absorption in the tissue, spectral PA measurements provide optical spectroscopic information 5 .
Most research efforts reported so far on extracting blood oxygenation levels from PA measurements in vitro utilize the exponential rise in PA signals. This approach, however, is not feasible for micro-vascular imaging in vivo, where peak amplitude value of PA signal from different structures is frequently the only parameter that can be separated in time. Here we report on some experimental considerations for blood oxygenation (SO 2 ) level measurements in subcutaneous vessels in vivo from peak amplitudes of spectral PA measurements obtained using a photo-acoustic system, and also analyze the factors that affect the accuracy of these measurements. Figure 1(a,b) show the experimental setup of our photoacoustic microscopy system. A Q-switched pulsed Nd:YAG laser (Brilliant B, BigSky) acts as the pumping source for a tunable dye laser (ND6000, Continuum), which delivers, after attenuation, 3 mJ light pulses to a 0.62-mm diameter optical fiber. The laser pulse width is 6.5 ns, and the pulse repetition rate is 10 Hz. The fiber output is positioned coaxially with a focuses ultrasonic transducer (Panametrics) on a three-dimensional precision mechanical scanner, as shown in Fig. 1b . The transducer has a center frequency of 50 MHz with a nominal bandwidth of 70%; it is attached to an in-house-constructed concave lens (aperture diameter D = 5.5 mm and free working distance L = 5.6 mm). The laser light from the fiber is expanded by a conical lens and then focused through an optical condenser with an NA of 1.1. The optical focal region overlaps with the focal spot of the ultrasonic transducer, thus forming a confocal optical dark-field illumination and ultrasonic detection configuration. Side illumination renders the assumption of omni-directional diffuse illumination of the imaging volume plausible. Photoacoustic signals received by the ultrasonic transducer are amplified by a low-noise amplifier (ZFL-500LN, Mini-Circuits) and recorded by a digital oscilloscope. To avoid the influence of laser output power instability, part of the laser beam is diverted to a silicon photo-diode, which is used to normalize the photoacoustic signal. The transducer is immersed in water in a plastic container with an opening at the bottom that is sealed with a thin disposable polyethylene membrane. The sample (animal) is placed outside the container below the membrane, and the ultrasonic coupling is further secured by coupling gel. Water temperature in the container is stabilized at 38 o C.
MATERIALS AND METHODS

Experimental equipment
Using a 50 MHz transducer (0.44 NA), the PAM system can image up to 3mm deep with a lateral resolution of 40-120 µm in vivo depending on the imaging depth, and high axial resolution of 15 to 30 µm 6, 7 . With other transducers used in this study (25MHz, 0.26NA and 10MHz, 0.26NA), the resolution degrades with the transducer central frequency and numerical aperture. Time history of photoacoustic signal recorded at each position along tissue surface forms so-called A-line, peaks of which are related to boundaries of the optically absorbing structures, peak amplitudes to absorption coefficients and arrival times to the distance to absorber along ultrasonic transducer axis. A gray-scale plot of the envelopes of time histories of the received photoacoustic signals versus the one-dimensional transducer position along scanning axis parallel to the skin surface forms B-scan image several of which are shown in Fig. 1 
Theoretical fundamentals
Several parameters, such as sound absorption in biological media, vessel (modeled here by a cylindrical tube) diameter, ultrasonic transducer focal position, and illumination condition (which itself is a function of depth), tissue optical absorption, µ a , and scattering, µ s can influence spectral PA measurements. Nevertheless, it can be reasonably stated that the magnitude of the PA signal from a blood vessel, 
The error function at convergence is non-zero due to the presence of true random errors (noise), which can be nullified by repeating the measurements, and the presence of systematic or modeling errors, which are caused by the influence of neighboring absorbers, sample inhomogeneity, process nonlinearity, errors in the theoretical model, and so on. Repetitive measurements do not decrease systematic errors, and in principle, systematic errors must be estimated independently which seems to be extremely complicated and virtually impossible in biological systems where one cannot, for example, replace a structure of interest under investigation with a known target and perform a complete system calibration. However, some estimate of unbiased systematic error can be made using the error at convergence as an estimator, and for lack of better knowledge, systematic errors can be assumed to be normally distributed and independent of optical wavelength. In vitro data shows almost zero bias; however, in vivo measurements produce significant bias, which will be discussed later in detail.
Taylor series linear expansion can be used to express relative changes in measured PA signals 
Assuming that measurement error is a wavelength independent additive error with variance
Ê is the residual value of E at convergence, (3) can be used to estimate covariance of inverted parameters:
Consequently, the variance bounds for a single parameter , respectively, using a linear regression technique 11 that assumes that the PA signal is linearly proportional to the optical absorption of hemoglobin and the optical fluence at the blood vessel surface: 
where, K is the unknown coefficient of proportionality between the incident light intensity and the PA signal magnitude, believed to be wavelength independent. Equation (6) Figure 2 Error propagation factor (EPF) for the inversion of SO2 at different optical spectral bands. The solid lines show EPF at SO2 values ranging from 100% (thick solid line) to 60% in 20% steps; the HbR and HbO2 optical spectra are plotted for reference purposes.
Using (5) and (6), the EPF for SO 2 can be estimated. The error propagation factors (EPF) for the SO 2 inversion for four wavelengths 6nm apart are plotted against the wavelength in Fig. 2 for SO 2 values changing from 100% to 60% in steps of 20%. The choice of narrow spectra; region alleviates the influence of other chromophores such as melanin, which have weak, but noticeable spectral dependence and also decrease the measurement time. Several distinct minima are noticeable around 575nm, 785nm, and 1 µm. However, hemoglobin absorption at the NIR and IR wavelengths is almost two orders smaller than at 575nm, which increases the influence of noise and other absorbers, especially melanin and water. Moreover, at longer wavelengths, scattering is more pronounced owing to low blood absorption at these wavelengths, thus complicating the calculation of the PA signals from the blood vessels. Accordingly, the optical range of 578-596 nm has been chosen for in vivo SO 2 measurements.
Equation (6) is valid only for small light absorption when 1 << a a µ , where a is the vessel radius and a µ is the optical absorption in blood. However, in the chosen spectral range and transducer frequency band, it is not true for majority of detectable blood vessels. Correspondingly, prior to applying the method for in vivo measurements, the linearity of the PA signal amplitude dependence on a µ for highly absorptive objects, 1 ≥ a a µ , must be experimentally proved. Measurements were performed using a 5 MHz transducer. This represents scaled model of blood vessel typically imaged by PAM; all problem length parameters -light absorption length, ultrasonic wavelength and cylinder radius are ten times bigger than in typical situation in vivo. Fig. 3b shows the peak amplitudes of the experimentally measured PA signals with 100 times averaging from a 0.25 mm diameter tube filled with ink samples of different concentrations covering the absorption range of whole blood in the visible spectrum. Measurements were acquired using a 50 MHz central frequency transducer; however, due to frequency dependent ultrasonic absorption in the tube material, the measured central frequency was near 25 MHz. The experimental data coincide with a linear fit up to 2 ≈ a a µ . There is a good correspondence between the experimental and theoretical data calculated by convolving the experimentally measured transient response of the ultrasonic transducer with the time domain photoacoustic pressure for cylindrically symmetric problems 12 with instant heat deposition for homogeneous cylinders uniformly illuminated by omni-directional scattered light given by:
RESULTS AND DISCUSSION
In vitro measurements
10
Fig . 4 shows a plot of in vitro SO 2 measurements performed on whole bovine blood using PAM against NIR spectrophotometric SO 2 measurements at different oxygenation levels using 25 MHz and 10 MHz transducers. The PA measurements were performed on bovine blood samples of different oxygenation levels anti-coagulated with citrate dextrose solution. Two stock samples of fully oxygenated and deoxygenated blood were prepared by saturating the bovine blood with pure oxygen at 6 o C and carbon dioxide at 36
respectively. Four more blood samples at different oxygenation levels were prepared by mixing the two stock samples in preset volumetric ratios 13 . As a standard for comparison, spectrophotometric (GENESYS 20, Thermo Electron) measurements in the wavelength range of 700-1000 nm in steps of 4 nm were obtained on saponin-hemolyzed samples 14 . Single point measurements from the samples injected into tubes of 0.25mm diameter were acquired using the PAM system at 12 wavelengths between 576 and 598 nm in steps of 2 nm. The inversion technique previously described was used to quantify the SO 2 level of each sample. Measurements at 25 MHz agreed with the optical measurements with a systematic error (accuracy) of ~1% , which may be fortuitous. Nevertheless, the variance of the PA measurements does not exceed 1%, which indicates the high sensitivity of PAM in measuring SO 2 . Phantom and in vitro studies demonstrate high linearity in the PA peak amplitude measurements with respect to a µ and high accuracy and sensitivity of PAM in quantitative measurements of SO 2 within its realm of application. The effect of transducer focus on the SO 2 measurements was found to be negligibly small. With a 25 MHz transducer, the highest deviation of SO 2 measured at ±0.5 mm from the transducer focus from the SO 2 value calculated at the focus does not exceed 2%.
In vivo measurements
As the next progressive step, in vivo spectral PA measurements were conducted on Sprague Dawley rats (~200 g, Charles River Breeding Laboratories). All experimental animal procedures were carried out in conformity with the guidelines of the United States National Institutes of Health 15 . The laboratory animal protocol for this work was approved by the ULAC of Texas A&M University. Hair was removed from the region of interest prior to imaging using commercial hair remover lotion. Intramuscular injection of 87 mg/kg Ketamine plus 13 mg/kg Xylasine was administered to anesthetize the rat, and the animal was kept motionless throughout the experiment with supplemental injections of a similar anesthetic mixture (~50 mg/kg/hour). The area to be imaged was fixed using an in-house made holder and water and ultrasound gel were used to provide ultrasound coupling. The body temperature of the animal was maintained throughout the experiment. Spectral images were obtained at the four wavelengths of 578 nm, 584 nm, 590 nm, 596 nm. A pulse oximeter (Nonin Medical, Inc) was used to monitor the arterial blood saturation and heart rate of the animal. The animal recovered after the experiment without noticeable health problems. Figure 5 C-scan (maximum intensity projection) images of rat skin vasculature taken with a 50 MHz transducer. Pixel brightness represents the PA intensity. Bar size is 1mm; each image was normalized on its maximum brightness value. Figure 5 shows the photoacoustic maximum intensity projection images of the vascular distribution in the dorsal dermis (the upper lumbar area left of the vertebra) of Sprague Dawley rats taken with a 50 MHz transducer at 578 nm, 584 nm, 590 nm, and 596 nm, respectively. Each image is normalized on its maximum brightness value. As one can see, different blood vessels have different relative contrast levels at short and long wavelengths, possibly due to different blood oxygenation levels in the veins and arteries. Data in Fig. 5 was used for SO 2 measurements. The statistical distribution of the SO 2 values over the area presented in Fig.5 is shown in Fig. 8 . The SO 2 data was weighted on PA amplitude at the isosbestic wavelength of 584 nm to discriminate erroneous data from areas between blood vessels. As one can see, not all measured SO 2 lies within the physiologically possible range. Under normal conditions, the arterial blood oxygenation level is expected to be about 98%, and the level in venous blood is about 89% 16 . The measured SO 2 values do not match these numbers, which indicates the influence of factors that may be specific to in vivo PA measurement. Most plausibly, the optical absorption caused by blood in the capillary network in skin tissue imparts its spectral signature on the fluence reaching the blood vessels of interest. These factors are defined by the tissue properties and must be measured independently. Laser wavelength (nm) Figure 7 . (a)Insertion of 50 µm thick black polyethylene film under rat dermis and (b) the spectra of PA signals from the black insert taken in vivo.
To measure skin optical attenuation, black polyethylene film was inserted under the rat skin as shown in Fig.  7a . During the experiment, a Pulse Oximeter (8600 V, Nonin Medical, MN) was used to monitor the heart rate and arterial blood oxygenation which was 98%. PAM images of 2mm X 2mm area enclosing the black insert were acquired at 15 wavelengths. The spectra on is molar extinction of hemoglobin at a given oxygenation level. As it can be seen, the PA signal amplitude varies significantly (up to ±30%) along the surface of the insert; however, PA optical wavelength dependence is preserved. The relative stability of the dermal spectral properties permits the following compensation technique. Owing to
